Investor Presentation Q1 2023

115 Investor presentation First three months of 2023 GLP-1 market share and market growth in Region China 160% 120% 80% 40% GLP-1 market growth and Novo Nordisk market share 0% Feb 2020 -NN market share -Market growth (right axis) GLP-1 market size and growth DKK billion 160% 120% 103% Region China ~102% 1 0 4 1 102% 80% 67% 2 67% ~103% 66.9% 40% 66.7% 0% Feb Feb Novo Nordisk Eli Lilly Others 2023 2022 Feb 2023 Novo Nordisk Competitors NN share of growth NN growth (right axis) Source: IQVIA, Feb 2023, Value, MAT; NN: Novo Nordisk; Region China covers Mainland China, Taiwan, and Hong Kong

View entire presentation